Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZX75
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,511
Award facts
- Contract value 100% obligated
- $2,510.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $2,510.63 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Exparel 266 mg/20 ml vials. This delivery order is issued without a set-aside designation and carries an ultimate completion date of September 17, 2025. The contract represents a direct pharmaceutical supply fulfillment for DLA's medical logistics operations supporting Department of Defense healthcare facilities.
This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA through the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that authorizes the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies. As a established federal supplier since 2001, DMS Pharmaceutical Group leverages its woman-owned small business status to provide branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. Exparel, a liposomal bupivacaine product used for local anesthetic infiltration, represents the type of specialty pharmaceutical product critical to military surgical and medical operations that the company routinely distributes through this DLA procurement vehicle.
Quick answers
Who was awarded contract SPE2DB25FZX75?
SPE2DB25FZX75 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FZX75 worth?
The government has obligated $2,511 on SPE2DB25FZX75.
Is contract SPE2DB25FZX75 an order under another contract?
Yes. SPE2DB25FZX75 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX75 competed?
The extent of competition for SPE2DB25FZX75 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award